vs

Side-by-side financial comparison of Amgen (AMGN) and LITHIA MOTORS INC (LAD). Click either name above to swap in a different company.

LITHIA MOTORS INC is the larger business by last-quarter revenue ($9.3B vs $8.6B, roughly 1.1× Amgen). Amgen runs the higher net margin — 21.1% vs 1.1%, a 20.0% gap on every dollar of revenue. On growth, Amgen posted the faster year-over-year revenue change (5.8% vs 1.0%). Over the past eight quarters, Amgen's revenue compounded faster (1.4% CAGR vs 0.2%).

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.

Lithia Motors, Inc. is an American nationwide automotive dealership group headquartered in Medford, Oregon. As of 2025, Lithia is the largest automotive retailer in the United States by revenue, ahead of competitors such as AutoNation and Penske Automotive Group. As of December 31, 2024, Lithia operates 459 dealership locations across the United States, Canada, and the United Kingdom. The company employs approximately 30,000 people worldwide.

AMGN vs LAD — Head-to-Head

Bigger by revenue
LAD
LAD
1.1× larger
LAD
$9.3B
$8.6B
AMGN
Growing faster (revenue YoY)
AMGN
AMGN
+4.7% gap
AMGN
5.8%
1.0%
LAD
Higher net margin
AMGN
AMGN
20.0% more per $
AMGN
21.1%
1.1%
LAD
Faster 2-yr revenue CAGR
AMGN
AMGN
Annualised
AMGN
1.4%
0.2%
LAD

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AMGN
AMGN
LAD
LAD
Revenue
$8.6B
$9.3B
Net Profit
$1.8B
$102.0M
Gross Margin
68.2%
15.3%
Operating Margin
30.9%
3.6%
Net Margin
21.1%
1.1%
Revenue YoY
5.8%
1.0%
Net Profit YoY
5.9%
EPS (diluted)
$3.34
$4.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMGN
AMGN
LAD
LAD
Q1 26
$8.6B
$9.3B
Q4 25
$9.9B
$9.2B
Q3 25
$9.6B
$9.7B
Q2 25
$9.2B
$9.6B
Q1 25
$8.1B
$9.2B
Q4 24
$9.1B
$9.2B
Q3 24
$8.5B
$9.2B
Q2 24
$8.4B
$9.2B
Net Profit
AMGN
AMGN
LAD
LAD
Q1 26
$1.8B
$102.0M
Q4 25
$1.3B
$136.9M
Q3 25
$3.2B
$217.1M
Q2 25
$1.4B
$256.1M
Q1 25
$1.7B
$209.5M
Q4 24
$627.0M
$216.1M
Q3 24
$2.8B
$209.1M
Q2 24
$746.0M
$214.2M
Gross Margin
AMGN
AMGN
LAD
LAD
Q1 26
68.2%
15.3%
Q4 25
69.8%
14.9%
Q3 25
67.8%
15.2%
Q2 25
67.2%
15.5%
Q1 25
63.6%
15.4%
Q4 24
65.7%
15.0%
Q3 24
61.1%
15.5%
Q2 24
61.4%
15.4%
Operating Margin
AMGN
AMGN
LAD
LAD
Q1 26
30.9%
3.6%
Q4 25
27.6%
3.7%
Q3 25
26.4%
4.4%
Q2 25
28.9%
4.4%
Q1 25
14.5%
4.4%
Q4 24
25.4%
4.5%
Q3 24
24.1%
4.6%
Q2 24
22.8%
4.3%
Net Margin
AMGN
AMGN
LAD
LAD
Q1 26
21.1%
1.1%
Q4 25
13.5%
1.5%
Q3 25
33.7%
2.2%
Q2 25
15.6%
2.7%
Q1 25
21.2%
2.3%
Q4 24
6.9%
2.4%
Q3 24
33.3%
2.3%
Q2 24
8.9%
2.3%
EPS (diluted)
AMGN
AMGN
LAD
LAD
Q1 26
$3.34
$4.28
Q4 25
$2.45
$5.90
Q3 25
$5.93
$8.61
Q2 25
$2.65
$9.87
Q1 25
$3.20
$7.94
Q4 24
$1.17
$8.09
Q3 24
$5.22
$7.80
Q2 24
$1.38
$7.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMGN
AMGN
LAD
LAD
Cash + ST InvestmentsLiquidity on hand
$12.0M
Total DebtLower is stronger
$57.3B
$6.4B
Stockholders' EquityBook value
$9.2B
$6.4B
Total Assets
$92.5B
$25.7B
Debt / EquityLower = less leverage
6.24×
1.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMGN
AMGN
LAD
LAD
Q1 26
$12.0M
Q4 25
$9.1B
Q3 25
$9.4B
$206.5M
Q2 25
$8.0B
$202.8M
Q1 25
$8.8B
$234.4M
Q4 24
$12.0B
Q3 24
$9.0B
$209.8M
Q2 24
$9.3B
$516.4M
Total Debt
AMGN
AMGN
LAD
LAD
Q1 26
$57.3B
$6.4B
Q4 25
$54.6B
$9.7B
Q3 25
$54.6B
Q2 25
$56.2B
Q1 25
$57.4B
Q4 24
$60.1B
$8.2B
Q3 24
$60.4B
Q2 24
$62.6B
Stockholders' Equity
AMGN
AMGN
LAD
LAD
Q1 26
$9.2B
$6.4B
Q4 25
$8.7B
$6.6B
Q3 25
$9.6B
$6.8B
Q2 25
$7.4B
$7.0B
Q1 25
$6.2B
$6.8B
Q4 24
$5.9B
$6.7B
Q3 24
$7.5B
$6.6B
Q2 24
$5.9B
$6.4B
Total Assets
AMGN
AMGN
LAD
LAD
Q1 26
$92.5B
$25.7B
Q4 25
$90.6B
$25.1B
Q3 25
$90.1B
$24.5B
Q2 25
$87.9B
$24.2B
Q1 25
$89.4B
$23.5B
Q4 24
$91.8B
$23.1B
Q3 24
$90.9B
$23.3B
Q2 24
$90.9B
$23.2B
Debt / Equity
AMGN
AMGN
LAD
LAD
Q1 26
6.24×
1.01×
Q4 25
6.31×
1.47×
Q3 25
5.67×
Q2 25
7.57×
Q1 25
9.24×
Q4 24
10.23×
1.23×
Q3 24
8.02×
Q2 24
10.57×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMGN
AMGN
LAD
LAD
Operating Cash FlowLast quarter
$2.2B
$212.2M
Free Cash FlowOCF − Capex
$1.5M
FCF MarginFCF / Revenue
0.0%
Capex IntensityCapex / Revenue
0.0%
1.0%
Cash ConversionOCF / Net Profit
1.20×
2.08×
TTM Free Cash FlowTrailing 4 quarters
$7.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMGN
AMGN
LAD
LAD
Q1 26
$2.2B
$212.2M
Q4 25
$1.6B
$123.7M
Q3 25
$4.7B
$-98.4M
Q2 25
$2.3B
$9.3M
Q1 25
$1.4B
$322.1M
Q4 24
$4.8B
$61.8M
Q3 24
$3.6B
$219.3M
Q2 24
$2.5B
$-148.4M
Free Cash Flow
AMGN
AMGN
LAD
LAD
Q1 26
$1.5M
Q4 25
$961.0M
$30.5M
Q3 25
$4.2B
$-207.3M
Q2 25
$1.9B
$-70.8M
Q1 25
$980.0M
$253.4M
Q4 24
$4.4B
$-17.7M
Q3 24
$3.3B
$157.1M
Q2 24
$2.2B
$-278.5M
FCF Margin
AMGN
AMGN
LAD
LAD
Q1 26
0.0%
Q4 25
9.7%
0.3%
Q3 25
44.4%
-2.1%
Q2 25
20.8%
-0.7%
Q1 25
12.0%
2.8%
Q4 24
48.4%
-0.2%
Q3 24
39.0%
1.7%
Q2 24
26.5%
-3.0%
Capex Intensity
AMGN
AMGN
LAD
LAD
Q1 26
0.0%
1.0%
Q4 25
6.5%
1.0%
Q3 25
4.6%
1.1%
Q2 25
4.0%
0.8%
Q1 25
5.0%
0.7%
Q4 24
4.1%
0.9%
Q3 24
3.0%
0.7%
Q2 24
2.8%
1.4%
Cash Conversion
AMGN
AMGN
LAD
LAD
Q1 26
1.20×
2.08×
Q4 25
1.20×
0.90×
Q3 25
1.46×
-0.45×
Q2 25
1.59×
0.04×
Q1 25
0.80×
1.54×
Q4 24
7.61×
0.29×
Q3 24
1.26×
1.05×
Q2 24
3.30×
-0.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMGN
AMGN

Product sales$8.2B95%
Other revenues$400.0M5%

LAD
LAD

New vehicle$4.4B47%
Used vehicle$3.5B38%
Aftersales$1.0B11%
Finance and insurance$359.7M4%

Related Comparisons